Catalyst Wire Dossier Catalyst Wire Dossier

Autologous tumor-infiltrating lymphocyte therapy

tumor-infiltrating lymphocytes · Grit Biotechnology
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous tumor-infiltrating lymphocyte therapy, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors [EARLY_Phase 1]

See pricing